SCIENTIFIC TALK AMD | 11 ottobre 2022 | ore 17 Share Post navigation Metabolomic profiling of the effects of dapagliflozin in heart failure with reduced ejection fraction: DEFINE-HFRationale and design of the phase 3 development programme (ONWARDS 1–6 trials) investigating once‐weekly insulin icodec in diabetes
